Compared with non-NAFLD participants, those with NAFLD had strongly elevated fatty liver index (64.9 vs 46.9) and hepatic steatosis index (43.7 vs 36.9), as well as on average higher BMI (mean ± SD: 29.9 ± 4.4), SBP (117.6 ± 16.2), DBP (77.3 ± 10.5), and metabolic variables including total cholesterol (191 ± 40), triglycerides (174 ± 97), fasting glucose (102 ± 31), AST (21 ± 10), and ALT (26 ± 17). This evidence concerns the gene GPT and fatty liver disease.